Targeted antimicrobial use admission provides an actionable denominator for evaluating inpatient length of therapy.
Publication
, Journal Article
Dyer, A; Dodds-Ashley, E; Davis, A; Johnson, M; Jones, T; Moehring, RW
Published in: Antimicrob Steward Healthc Epidemiol
2025
Our novel antibiotic use denominator, targeted antimicrobial use admission, is defined as an inpatient admission in which a select agent or group of agents is administered. Used in combination with length of therapy, it allows programs to quickly assess agent inpatient durations.
Duke Scholars
Published In
Antimicrob Steward Healthc Epidemiol
DOI
EISSN
2732-494X
Publication Date
2025
Volume
5
Issue
1
Start / End Page
e237
Location
England
Citation
APA
Chicago
ICMJE
MLA
NLM
Dyer, A., Dodds-Ashley, E., Davis, A., Johnson, M., Jones, T., & Moehring, R. W. (2025). Targeted antimicrobial use admission provides an actionable denominator for evaluating inpatient length of therapy. Antimicrob Steward Healthc Epidemiol, 5(1), e237. https://doi.org/10.1017/ash.2025.10119
Dyer, April, Elizabeth Dodds-Ashley, Angelina Davis, Melissa Johnson, Travis Jones, and Rebekah W. Moehring. “Targeted antimicrobial use admission provides an actionable denominator for evaluating inpatient length of therapy.” Antimicrob Steward Healthc Epidemiol 5, no. 1 (2025): e237. https://doi.org/10.1017/ash.2025.10119.
Dyer A, Dodds-Ashley E, Davis A, Johnson M, Jones T, Moehring RW. Targeted antimicrobial use admission provides an actionable denominator for evaluating inpatient length of therapy. Antimicrob Steward Healthc Epidemiol. 2025;5(1):e237.
Dyer, April, et al. “Targeted antimicrobial use admission provides an actionable denominator for evaluating inpatient length of therapy.” Antimicrob Steward Healthc Epidemiol, vol. 5, no. 1, 2025, p. e237. Pubmed, doi:10.1017/ash.2025.10119.
Dyer A, Dodds-Ashley E, Davis A, Johnson M, Jones T, Moehring RW. Targeted antimicrobial use admission provides an actionable denominator for evaluating inpatient length of therapy. Antimicrob Steward Healthc Epidemiol. 2025;5(1):e237.
Published In
Antimicrob Steward Healthc Epidemiol
DOI
EISSN
2732-494X
Publication Date
2025
Volume
5
Issue
1
Start / End Page
e237
Location
England